Julien Pacaud
From this contributor
Fear and loathing on study section: Reviewing grant proposals while the system is burning
As grants are canceled, delayed and subject to general uncertainty, participating in study sections can feel futile. But it’s more important than ever.
Fear and loathing on study section: Reviewing grant proposals while the system is burning
Maiken Nedergaard’s power of disruption
The award-winning researcher’s discoveries have changed the way we think about the brain; that’s exactly what her critics dislike.
Maiken Nedergaard’s power of disruption
Debate remains over changes in DSM-5 a decade on
Changes to the DSM-5’s diagnostic criteria for autism were meant to add clarity, but they also generated new questions.
Debate remains over changes in DSM-5 a decade on
New statistical method may spare lab animals
An online tool could help researchers limit the number of animals needed to power their studies.
Book Review: ‘Nobody’s Normal’ chronicles the intertwined history of mental illness and stigma
Anthropologist and autism expert Richard Roy Grinker’s latest title reveals how our definitions of mental illnesses and notions of ‘normality’ reek of cultural biases that stop many from seeking help.
Book Review: ‘Nobody’s Normal’ chronicles the intertwined history of mental illness and stigma
Explore more from The Transmitter
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.